NCT07537257 2026-04-17
VEN+IDAC vs IDAC in AML
Guangdong Second Provincial General Hospital
Phase 2/3 Enrolling by invitation
Clinical Trials
5 trialsNCT07264010 2025-12-04
Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single-arm, Multicenter Clinical Study
Nanfang Hospital, Southern Medical University
Phase 2/3 Not yet recruiting
NCT02870777 2020-03-04
MRD-directed Therapy for Low-risk and Intermediate-risk AML.
Nanfang Hospital, Southern Medical University
Phase 2/3 Completed
NCT03665480 2018-10-09
The Effect of G-CSF on MRD After Induction Therapy in Newly Diagnosed AML
Nanfang Hospital, Southern Medical University
Phase 2/3 Unknown
NCT00795756 2014-10-22
Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia
Northern Italy Leukemia Group
Phase 2/3 Completed